Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free SCNX Stock Alerts

Scienture (SCNX) Financials

Scienture logo
$0.41 -0.01 (-1.40%)
As of 01:50 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Scienture

Annual Income Statements for Scienture

This table shows Scienture's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -1.12 -2.76 0.29 0.01 -0.28 -2.54 -5.32 -3.47 -18 9.07 -42
Consolidated Net Income / (Loss)		 -1.12 -2.76 0.29 0.01 -0.28 -2.54 -5.32 -3.91 -18 9.07 -42
Net Income / (Loss) Continuing Operations		 -0.26 -1.17 0.29 0.01 -0.28 -2.54 -5.32 -2.40 -8.48 -18 -42
Total Pre-Tax Income 		-0.26 -1.20 0.22 0.01 -0.36 -2.54 -5.32 -2.40 -8.48 -19 -44
Total Operating Income		 -0.14 -1.01 0.40 -0.09 0.13 -2.51 -5.29 -2.92 -4.40 -15 -43
Total Gross Profit		 2.72 0.00 2.93 3.38 4.87 5.71 4.75 5.52 0.05 0.01 0.33
Total Revenue		 2.91 0.00 2.93 3.83 7.44 17 9.89 10 1.36 0.14 0.43
Operating Revenue		 2.91 - 2.93 3.83 7.44 17 9.89 10 1.36 0.14 0.43
Total Cost of Revenue		 0.19 0.00 0.00 0.45 2.57 11 5.14 4.73 1.31 0.13 0.10
Operating Cost of Revenue		 0.19 - 0.00 0.45 2.57 11 5.14 4.73 1.31 0.13 0.10
Total Operating Expenses		 2.86 1.01 2.54 3.47 4.75 8.21 10 8.44 4.45 15 43
Selling, General & Admin Expense		 2.86 3.49 2.54 3.47 4.38 7.49 2.99 2.16 2.21 8.14 10
Research & Development Expense		 - - - - - - - - 0.00 2.24 1.96
Other Operating Expenses / (Income)		 - -2.48 - 0.00 0.37 - 6.35 5.45 0.73 2.53 2.12
Impairment Charge		 - - - - 0.00 0.73 0.00 - - 0.00 26
Other Special Charges / (Income)		 - - - - - - 0.70 0.83 1.51 1.81 2.07
Total Other Income / (Expense), net		 -0.12 -0.19 -0.17 0.10 -0.48 -0.03 -0.02 0.51 -4.09 -4.08 -0.92
Interest Expense		 0.12 0.15 0.17 0.06 0.23 0.03 0.02 0.34 1.14 1.34 4.08
Interest & Investment Income		 - - - 0.00 -0.25 - - 0.02 0.00 0.14 0.30
Other Income / (Expense), net		 - -0.04 - 0.16 - - 0.00 0.83 -2.95 -2.88 3.21
Income Tax Expense		 - - - - - - - - 0.00 -0.53 -1.99
Net Income / (Loss) Discontinued Operations		 -0.86 0.20 - - - - - -1.51 -9.36 27 0.00
Basic Earnings per Share		 - ($0.09) $0.01 $0.00 ($0.05) ($0.33) - ($6.15) ($23.35) $2.69 ($2.70)
Weighted Average Basic Shares Outstanding		 31.32M 31.54M 31.96M 5.38M 5.93M 7.71M 8.14M 564.86K 764.06K 3.38M 15.35M
Diluted Earnings per Share		 - ($0.09) $0.01 $0.00 ($0.05) ($0.33) ($0.65) ($6.13) ($23.35) $2.48 ($2.70)
Weighted Average Diluted Shares Outstanding		 31.32M 31.54M 34.09M 5.83M 5.93M 7.71M 8.14M 566.61K 2.38M 3.65M 15.35M
Weighted Average Basic & Diluted Shares Outstanding		 31.32M 31.54M 31.99M 33.73M 5.93M 7.71M 8.14M 10.11M - 12.52M 40.63M

Quarterly Income Statements for Scienture

This table shows Scienture's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -3.53 -12 21 -1.83 -3.18 -7.16 -3.06 -6.72 -3.61 -28 -3.40
Consolidated Net Income / (Loss)		 -3.53 -12 21 -1.83 -3.18 -7.16 -3.06 -6.72 -3.61 -28 -3.40
Net Income / (Loss) Continuing Operations		 -0.09 -5.03 -6.63 -1.62 -3.18 -6.80 -3.06 -6.72 -3.61 -28 -3.40
Total Pre-Tax Income 		-0.09 -5.03 -6.63 -1.62 -3.18 -7.34 -3.06 -6.72 -3.61 -30 -3.40
Total Operating Income		 -0.76 -2.23 -5.49 -1.50 -3.50 -4.21 -3.57 -5.16 -4.36 -30 -3.51
Total Gross Profit		 0.04 -0.13 0.00 -0.00 0.00 0.00 0.00 0.00 0.57 -0.24 0.05
Total Revenue		 0.39 0.11 0.00 0.02 0.06 0.05 0.01 0.00 0.59 -0.17 0.06
Operating Revenue		 0.39 0.11 0.00 0.02 0.06 0.05 0.01 0.00 0.59 -0.17 0.06
Total Cost of Revenue		 0.35 0.24 0.00 0.02 0.06 0.05 0.01 0.00 0.02 0.08 0.00
Operating Cost of Revenue		 0.35 0.24 0.00 0.02 0.06 0.05 0.01 0.00 0.02 0.08 0.00
Total Operating Expenses		 0.80 2.10 5.49 1.49 3.50 4.22 3.57 5.16 4.94 29 3.55
Selling, General & Admin Expense		 0.36 1.11 4.88 0.92 0.76 1.57 1.77 3.14 3.49 1.94 2.01
Research & Development Expense		 0.00 - 0.00 0.00 1.25 0.98 0.57 0.84 0.17 0.37 0.79
Other Operating Expenses / (Income)		 0.03 0.27 0.27 0.40 0.87 0.99 0.76 0.80 0.26 0.30 0.42
Other Special Charges / (Income)		 0.41 0.72 0.34 0.17 0.62 0.68 0.47 0.38 1.02 0.20 0.33
Total Other Income / (Expense), net		 0.67 -2.80 -1.14 -0.13 0.31 -3.12 0.51 -1.56 0.75 -0.61 0.11
Interest Expense		 0.25 0.65 0.10 0.00 0.22 1.01 0.67 0.65 1.80 0.96 0.04
Interest & Investment Income		 0.00 - 0.06 0.04 0.03 0.00 0.03 0.06 0.00 0.21 0.13
Other Income / (Expense), net		 0.93 -2.15 -1.10 -0.17 0.50 -2.11 1.15 -0.97 2.56 0.47 0.01
Income Tax Expense		 - - 0.00 0.00 0.00 -0.53 0.00 0.00 0.00 -1.99 0.00
Basic Earnings per Share		 ($4.57) ($15.27) $20.49 ($1.30) ($1.34) ($2.12) ($0.33) ($0.48) ($0.19) ($1.70) ($0.08)
Weighted Average Basic Shares Outstanding		 771.19K 764.06K 1.04M 1.41M 2.37M 3.38M 9.43M 14.14M 18.96M 15.35M 40.63M
Diluted Earnings per Share		 ($4.57) ($15.27) $16.77 ($1.30) ($1.34) ($2.12) ($0.33) ($0.48) ($0.19) ($1.70) ($0.08)
Weighted Average Diluted Shares Outstanding		 2.36M 2.38M 1.27M 1.41M 2.37M 3.65M 9.43M 14.14M 18.96M 15.35M 40.63M
Weighted Average Basic & Diluted Shares Outstanding		 - 0.00 1.41M 1.46M 8.58M 12.52M 13.12M 16.13M 40.63M 40.63M 40.63M

Annual Cash Flow Statements for Scienture

This table details how cash moves in and out of Scienture's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -0.62 -0.06 0.17 0.69 2.00 3.05 -2.80 -2.03 -1.09 0.31 6.35
Net Cash From Operating Activities		 0.09 -3.68 0.17 0.27 0.14 -2.21 -2.57 -1.56 -2.23 -14 -13
Net Cash From Continuing Operating Activities		 0.21 -0.50 0.17 0.27 0.14 -2.21 -2.57 -0.20 3.65 -13 -13
Net Income / (Loss) Continuing Operations		 -0.26 -4.35 0.29 0.01 -0.28 -2.54 -5.32 -2.40 -8.48 -19 -44
Consolidated Net Income / (Loss)		 -1.12 -2.76 0.29 0.01 -0.28 -2.54 -5.32 -2.40 -8.48 -19 -44
Depreciation Expense		 0.00 - - 0.00 0.01 0.01 0.01 0.01 0.02 0.00 0.00
Amortization Expense		 0.10 0.11 0.09 0.00 0.09 0.10 0.13 0.18 1.03 0.96 3.65
Non-Cash Adjustments To Reconcile Net Income		 0.38 0.19 0.30 0.18 1.00 2.74 1.52 1.75 5.69 7.13 30
Changes in Operating Assets and Liabilities, net		 -0.01 0.37 -0.50 0.08 -0.67 -2.52 1.09 0.26 5.39 -2.60 -3.03
Net Cash From Discontinued Operating Activities		 - - - - - - - -1.37 -5.87 -0.98 0.00
Net Cash From Investing Activities		 0.00 0.00 0.00 -0.27 -0.33 -0.04 -0.02 -0.43 -0.28 28 0.00
Net Cash From Continuing Investing Activities		 0.00 0.00 0.00 -0.27 -0.33 -0.04 -0.02 0.00 -0.34 -2.38 0.00
Purchase of Property, Plant & Equipment		 - - 0.00 -0.02 -0.08 -0.04 -0.02 0.00 0.00 -0.01 0.00
Purchase of Investments		 - - - -0.25 - - - - 0.00 -2.50 0.00
Divestitures		 - - - - - - - - 0.00 0.13 0.00
Net Cash From Discontinued Investing Activities		 - - - - - - - -0.43 0.07 30 0.00
Net Cash From Financing Activities		 0.41 0.62 -0.00 0.68 2.19 5.30 -0.21 -0.04 1.41 -13 20
Net Cash From Continuing Financing Activities		 0.41 0.62 -0.00 0.68 2.19 5.30 -0.21 0.24 1.91 -13 20
Repayment of Debt		 0.00 -0.15 -0.43 -0.12 -0.26 0.00 -0.23 0.00 -0.15 0.00 -9.78
Payment of Dividends		 - - - - - - 0.00 - 0.00 -15 0.00
Issuance of Debt		 0.41 0.47 0.18 - - - - 0.00 0.40 0.15 3.62
Issuance of Preferred Equity		 - - - - - - - - - 2.95 0.00
Issuance of Common Equity		 0.00 0.30 0.25 0.80 2.46 5.99 0.00 0.13 0.00 0.00 26
Other Financing Activities, net		 0.00 0.00 0.00 0.00 0.00 0.04 0.02 0.11 1.66 -1.22 -0.40
Net Cash From Discontinued Financing Activities		 - - - - - - - -0.28 -0.50 -0.01 0.00
Cash Interest Paid		 0.00 0.02 0.07 0.04 0.10 0.03 0.03 0.34 0.73 0.00 0.00
Cash Income Taxes Paid		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Quarterly Cash Flow Statements for Scienture

This table details how cash moves in and out of Scienture's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -0.70 -0.03 3.35 4.22 -7.14 -0.12 1.74 -2.03 0.34 6.31 -3.12
Net Cash From Operating Activities		 -0.60 -1.02 -10 4.22 -5.39 -2.91 -2.96 -2.03 -3.21 -5.18 -2.92
Net Cash From Continuing Operating Activities		 -0.78 5.68 -9.66 4.46 -5.39 -2.70 -2.96 -2.04 -3.21 -5.18 -2.92
Net Income / (Loss) Continuing Operations		 -0.09 -5.05 -6.63 -1.62 -3.18 -7.34 -3.06 -6.72 -3.61 -30 -3.40
Consolidated Net Income / (Loss)		 -0.09 -5.05 -6.63 -1.62 -3.18 -7.34 -3.06 - - -30 -3.40
Depreciation Expense		 0.00 0.01 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00
Amortization Expense		 0.23 0.70 0.01 0.01 0.03 0.91 0.52 0.50 1.76 0.86 0.47
Non-Cash Adjustments To Reconcile Net Income		 -0.92 5.14 5.21 0.17 -0.50 2.26 -0.07 3.77 -0.53 26 -0.00
Changes in Operating Assets and Liabilities, net		 0.00 4.88 -8.24 5.91 -1.74 1.47 -0.34 0.40 -0.83 -2.25 0.02
Net Cash From Investing Activities		 -0.21 -0.35 27 -0.00 0.12 - 0.00 - - - 0.00
Net Cash From Continuing Investing Activities		 0.14 -0.35 -2.50 - 0.12 - 0.00 - - - 0.00
Net Cash From Financing Activities		 0.11 1.34 -14 - -1.87 2.79 4.70 - 3.55 11 -0.20
Net Cash From Continuing Financing Activities		 0.61 1.34 -14 - -1.87 2.79 4.70 - 3.55 11 -0.20
Issuance of Debt		 - 0.20 0.00 - 0.31 -0.16 0.10 - 0.02 3.50 0.00
Issuance of Common Equity		 - - 0.00 - - - 4.60 - 6.87 15 0.00
Other Financing Activities, net		 0.39 1.31 -1.22 - - - 0.00 - - -0.40 -0.20
Cash Interest Paid		 - 0.49 0.73 -0.73 - - 0.00 - - - 0.00
Cash Income Taxes Paid		 - - 0.00 - - - 0.00 - - - 0.00

Annual Balance Sheets for Scienture

This table presents Scienture's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 2.03 0.00 0.62 2.23 5.57 9.79 5.77 3.71 13 105 84
Total Current Assets		 0.52 0.00 0.61 1.47 3.80 9.22 4.37 2.09 2.75 6.31 7.92
Cash & Equivalents		 0.08 - 0.18 0.87 2.87 5.92 3.12 1.09 0.00 0.31 6.66
Accounts Receivable		 0.35 0.00 0.32 0.43 0.79 1.89 0.98 0.63 1.22 4.15 0.73
Inventories, net		 - 0.00 0.00 0.08 0.06 1.26 0.06 0.07 0.00 0.00 0.21
Prepaid Expenses		 0.09 0.00 0.10 0.08 0.08 0.15 0.22 0.10 0.05 0.00 0.26
Other Current Assets		 0.01 0.00 0.00 - - - - - 0.00 0.53 0.05
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.02 0.17 0.16 0.10 0.07 0.01 0.02 0.02
Total Noncurrent Assets		 1.50 0.00 0.01 0.75 1.59 0.41 1.29 1.55 9.77 99 76
Noncurrent Note & Lease Receivables		 - - - - - - - - - 0.00 5.00
Intangible Assets		 - - - - - - - 0.00 0.00 76 71
Other Noncurrent Operating Assets		 - 0.00 0.01 0.02 0.87 0.41 1.29 1.10 0.20 0.22 0.27
Total Liabilities & Shareholders' Equity		 2.03 0.00 0.62 2.23 5.57 9.79 5.77 3.71 13 105 84
Total Liabilities		 1.76 0.00 0.93 1.38 1.43 1.11 2.00 3.37 12 26 14
Total Current Liabilities		 1.76 0.00 0.53 0.86 0.52 0.84 0.93 2.15 12 7.91 2.74
Accounts Payable		 0.22 0.00 0.11 0.40 0.33 0.26 0.48 0.53 1.46 2.90 1.44
Accrued Expenses		 0.25 0.00 0.16 0.14 0.10 0.22 0.27 0.27 0.16 1.31 0.66
Other Current Liabilities		 0.16 - - 0.00 0.09 0.13 0.18 0.96 2.08 0.99 0.64
Total Noncurrent Liabilities		 0.00 0.00 0.40 0.52 0.91 0.27 1.07 1.22 0.43 18 11
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - - - - 0.00 14 11
Other Noncurrent Operating Liabilities		 - - - 0.00 0.69 0.27 1.07 0.89 0.18 3.74 0.29
Commitments & Contingencies		 - - - - - - - - 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 0.27 0.00 -0.31 0.84 4.14 8.68 3.77 0.34 0.54 79 70
Total Preferred & Common Equity		 0.27 0.00 -0.31 0.84 4.14 8.68 3.77 0.76 0.54 79 70
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 0.27 0.00 -0.31 0.84 4.14 8.68 3.77 0.76 0.54 79 70
Common Stock		 5.92 0.00 7.81 8.96 13 20 20 20 34 118 151
Retained Earnings		 -5.65 0.00 -8.12 -8.11 -8.40 -11 -16 -20 -33 -39 -81

Quarterly Balance Sheets for Scienture

This table presents Scienture's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 22 17 15 94 106 104 105 81
Total Current Assets		 5.55 14 12 7.26 7.83 0.86 1.42 4.77
Cash & Equivalents		 0.03 3.50 7.72 0.58 2.05 0.02 0.36 3.54
Accounts Receivable		 0.97 9.05 2.24 4.52 4.05 0.00 0.59 0.72
Inventories, net		 3.03 0.01 0.01 0.01 - - 0.23 0.21
Prepaid Expenses		 0.25 0.17 0.80 0.78 0.42 0.29 0.24 0.25
Other Current Assets		 - - 0.07 0.07 0.00 0.55 0.00 0.05
Plant, Property, & Equipment, net		 0.29 0.01 0.01 0.02 0.02 0.02 0.02 0.02
Total Noncurrent Assets		 16 2.71 2.70 87 99 103 103 76
Noncurrent Note & Lease Receivables		 - - - - - 5.00 5.00 5.00
Intangible Assets		 9.45 - - 76 76 76 76 71
Other Noncurrent Operating Assets		 1.24 0.21 0.20 0.24 0.21 0.11 0.09 0.35
Total Liabilities & Shareholders' Equity		 22 17 15 94 106 104 105 81
Total Liabilities		 10 3.12 3.06 9.13 25 26 22 14
Total Current Liabilities		 9.09 2.95 2.90 5.41 7.46 7.69 7.35 2.80
Accounts Payable		 1.33 0.95 0.73 2.90 3.18 3.14 3.67 1.40
Accrued Expenses		 0.39 0.49 0.50 1.04 1.41 1.80 0.98 0.70
Other Current Liabilities		 2.15 1.50 1.67 1.20 0.35 0.23 0.16 0.70
Total Noncurrent Liabilities		 1.00 0.17 0.16 3.71 18 19 15 11
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - 14 14 14 11
Other Noncurrent Operating Liabilities		 0.98 0.17 0.16 1.46 3.12 3.64 1.29 0.00
Commitments & Contingencies		 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 12 14 12 85 81 78 83 67
Total Preferred & Common Equity		 12 14 12 85 81 78 83 67
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 12 14 12 85 81 78 83 67
Common Stock		 33 38 38 117 123 127 135 151
Retained Earnings		 -22 -25 -27 -32 -42 -49 -52 -84

Annual Metrics And Ratios for Scienture

This table displays calculated financial ratios and metrics derived from Scienture's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 31,269,160.00 31,660,827.00 31,985,827.00 32,285,827.00 38,986,459.00 8,093,199.00 8,166,457.00 9,318,708.00 1,247,169.00 8,576,795.00 40,630,815.00
DEI Adjusted Shares Outstanding		 347,435.00 351,787.00 355,398.00 358,731.00 433,183.00 539,547.00 544,430.00 621,247.00 1,247,169.00 8,576,795.00 40,630,815.00
DEI Earnings Per Adjusted Shares Outstanding		 -3.22 -7.85 0.81 0.03 -0.66 -4.70 -9.76 -5.59 -14.31 1.06 -1.02
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 94.66% -100.00% 0.00% 30.72% 94.07% 130.26% -42.24% 3.65% -86.69% -89.98% 215.87%
EBITDA Growth		 96.25% -2,829.12% 151.82% -84.67% 196.54% -1,193.02% -114.35% 63.26% -232.40% -163.95% -115.09%
EBIT Growth		 83.97% -662.28% 137.81% -81.26% 69.17% -2,101.74% -111.13% 60.54% -251.68% -139.37% -124.05%
NOPAT Growth		 90.42% -634.86% 156.03% -122.18% 200.05% -2,101.74% -111.13% 44.90% -50.77% -234.38% -189.71%
Net Income Growth		 44.48% -147.06% 110.47% -96.87% -3,247.02% -791.63% -109.61% 26.45% -356.37% 150.81% -557.90%
EPS Growth		 0.00% 0.00% 111.11% -96.87% -3,247.02% -560.00% -96.97% 26.45% -280.91% 110.62% -208.87%
Operating Cash Flow Growth		 108.49% -4,168.73% 104.67% 59.25% -48.14% -1,662.18% -15.87% 39.03% -42.22% -541.08% 6.21%
Free Cash Flow Firm Growth		 106.06% -1,738.08% 125.16% -427.84% 20.31% -453.21% 57.86% 47.91% -273.49% -3,412.93% 88.02%
Invested Capital Growth		 -404.85% 100.00% 0.00% 380.40% 82.32% 99.83% -78.30% -205.20% -61.21% 7,573.35% -22.68%
Revenue Q/Q Growth		 -28.84% -100.00% 755.36% 16.72% 5.72% 1.77% 4.15% -6.50% -53.41% -30.02% -33.94%
EBITDA Q/Q Growth		 96.51% -117.25% 39.64% -78.17% -9.50% -411.97% 22.79% 36.78% -176.40% -11.74% -175.34%
EBIT Q/Q Growth		 86.05% -91.90% 75.10% -78.05% -27.49% -348.96% 22.35% 32.04% -165.60% -12.43% -136.15%
NOPAT Q/Q Growth		 86.05% -85.00% 75.10% -125.98% -27.49% -348.96% 22.35% 5.10% -57.41% -15.62% -146.12%
Net Income Q/Q Growth		 -5.51% 1.86% 198.30% -97.32% -1,348.48% -252.67% 22.32% -15.30% -138.52% 98.69% -101.96%
EPS Q/Q Growth		 0.00% 0.00% 200.00% -97.32% 0.00% -266.67% 22.62% -15.30% -153.53% 29.17% -150.00%
Operating Cash Flow Q/Q Growth		 107.85% -713.23% 105.23% -3.95% -61.33% -31.67% 10.12% 50.84% -14,969.70% -15.28% -20.39%
Free Cash Flow Firm Q/Q Growth		 0.00% -1,210.12% -31.85% -318.31% 43.20% 10.86% 3.13% 73.02% 84.53% -21.87% 9.60%
Invested Capital Q/Q Growth		 -145.00% -100.00% 0.00% 0.00% 29.44% -32.24% -38.05% -144.38% -106.54% -2.95% -25.21%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 93.48% 0.00% 100.00% 88.28% 65.50% 33.33% 47.99% 53.85% 3.60% 4.39% 76.80%
EBITDA Margin		 -1.09% 0.00% 16.50% 1.94% 2.96% -14.04% -52.11% -18.47% -461.50% -12,157.79% -8,278.81%
Operating Margin		 -4.71% 0.00% 13.48% -2.29% 1.68% -14.64% -53.51% -28.45% -322.36% -10,758.70% -9,867.92%
EBIT Margin		 -4.71% 0.00% 13.48% 1.93% 1.68% -14.64% -53.51% -20.37% -538.47% -12,864.60% -9,125.15%
Profit (Net Income) Margin		 -38.36% 0.00% 9.86% 0.24% -3.82% -14.81% -53.75% -38.14% -1,308.34% 6,634.66% -9,618.03%
Tax Burden Percent		 435.41% 230.71% 130.48% 100.00% 79.78% 100.00% 100.00% 162.68% 210.35% -48.28% 95.41%
Interest Burden Percent		 187.19% 114.50% 56.06% 12.21% -284.69% 101.17% 100.45% 115.10% 115.51% 106.83% 110.47%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 463.41% -17.71% 7.58% -78.37% -203.99% 0.00% 0.00% -25.42% -40.97%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 419.42% 24.60% 35.43% -59.63% -167.44% 0.00% 0.00% 2,818.56% 598.26%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% -648.69% 21.10% -18.99% 38.80% 118.59% 0.00% 0.00% 48.19% -14.68%
Return on Equity (ROE)		 -238.85% -2,067.38% -185.29% 3.39% -11.41% -39.57% -85.40% -190.12% -4,031.44% 22.77% -55.65%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 263.41% -148.79% -50.74% -144.96% -75.31% 0.00% 0.00% -113.88% -15.39%
Operating Return on Assets (OROA)		 -8.44% 0.00% 127.97% 5.20% 3.21% -32.63% -68.03% -44.07% -90.43% -29.95% -41.67%
Return on Assets (ROA)		 -68.75% 0.00% 93.60% 0.64% -7.29% -33.01% -68.33% -82.52% -219.71% 15.45% -43.92%
Return on Common Equity (ROCE)		 -238.85% -2,067.38% -185.29% 3.39% -11.41% -39.57% -85.40% -209.55% -5,945.42% 22.77% -55.65%
Return on Equity Simple (ROE_SIMPLE)		 -418.39% 0.00% -92.64% 1.07% -6.87% -29.22% -141.00% -512.34% -3,290.03% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.10 -0.71 0.40 -0.09 0.09 -1.75 -3.70 -2.04 -3.08 -10 -30
NOPAT Margin		 -3.29% 0.00% 13.48% -2.29% 1.18% -10.25% -37.46% -19.91% -225.65% -7,531.09% -6,907.55%
Net Nonoperating Expense Percent (NNEP)		 -176.04% -904.06% 43.99% -42.30% -27.85% -18.74% -36.55% -90.13% -1,108.28% -2,843.98% -639.24%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -567.44% -12.49% -42.52%
Cost of Revenue to Revenue		 6.52% 0.00% 0.00% 11.72% 34.50% 66.67% 52.01% 46.15% 96.41% 95.61% 23.20%
SG&A Expenses to Revenue		 98.19% 0.00% 86.52% 90.57% 58.86% 43.73% 30.25% 21.03% 162.17% 5,954.14% 2,394.26%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1,636.89% 453.25%
Operating Expenses to Revenue		 98.19% 0.00% 86.52% 90.57% 63.82% 47.97% 101.50% 82.29% 325.96% 10,763.10% 9,922.19%
Earnings before Interest and Taxes (EBIT)		 -0.14 -1.04 0.40 0.07 0.13 -2.51 -5.29 -2.09 -7.34 -18 -39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.03 -0.93 0.48 0.07 0.22 -2.40 -5.15 -1.89 -6.29 -17 -36
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 127.67 0.00 0.00 41.67 6.45 3.07 3.18 3.06 7.44 0.66 0.30
Price to Tangible Book Value (P/TBV)		 127.67 0.00 0.00 296.54 7.82 3.07 3.18 3.06 7.44 0.00 0.00
Price to Revenue (P/Rev)		 11.70 0.00 11.90 9.19 3.59 1.56 1.21 0.23 2.96 379.75 48.01
Price to Earnings (P/E)		 0.00 0.00 120.67 3,894.43 0.00 0.00 0.00 0.00 0.00 5.72 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 157.02% 0.00%
Earnings Yield		 0.00% 0.00% 0.83% 0.03% 0.00% 0.00% 0.00% 0.00% 0.00% 17.47% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 207.33 42.94 16.12 7.03 13.72 0.00 0.00 0.67 0.22
Enterprise Value to Revenue (EV/Rev)		 11.76 0.00 12.06 9.18 3.24 1.23 0.90 0.13 2.96 401.73 32.58
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 73.08 474.18 109.43 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 89.48 475.15 192.21 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 89.48 0.00 274.59 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 378.88 0.00 205.94 128.65 169.77 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 628.40 0.00 157.42 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.88 0.00 -2.14 1.00 0.05 0.03 0.00 1.46 0.00 0.04 0.00
Long-Term Debt to Equity		 0.00 0.00 -1.30 0.62 0.05 0.00 0.00 0.97 0.00 0.01 0.00
Financial Leverage		 -1.24 -1.70 -1.55 0.86 -0.54 -0.65 -0.71 -1.01 -3.01 0.02 -0.02
Leverage Ratio		 3.47 7.59 -1.98 5.34 1.56 1.20 1.25 2.30 18.35 1.47 1.27
Compound Leverage Factor		 6.50 8.69 -1.11 0.65 -4.45 1.21 1.26 2.65 21.20 1.58 1.40
Debt to Total Capital		 46.81% 0.00% 188.01% 49.98% 5.15% 2.53% 0.00% 59.32% 0.00% 4.02% 0.00%
Short-Term Debt to Total Capital		 46.81% 0.00% 74.01% 19.04% 0.00% 2.53% 0.00% 19.77% 0.00% 3.28% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 114.00% 30.94% 5.15% 0.00% 0.00% 39.55% 0.00% 0.74% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -49.86% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 53.19% 0.00% -88.01% 50.02% 94.85% 97.47% 100.00% 90.54% 100.00% 95.98% 100.00%
Debt to EBITDA		 -7.37 0.00 1.38 11.38 1.02 -0.09 0.00 -0.26 0.00 -0.20 0.00
Net Debt to EBITDA		 -4.90 0.00 1.00 -0.34 -12.03 2.37 0.00 0.31 0.00 -0.18 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.84 7.04 1.02 0.00 0.00 -0.18 0.00 -0.04 0.00
Debt to NOPAT		 -2.45 0.00 1.69 -9.63 2.57 -0.13 0.00 -0.25 0.00 -0.32 0.00
Net Debt to NOPAT		 -1.63 0.00 1.22 0.29 -30.19 3.25 0.00 0.29 0.00 -0.29 0.00
Long-Term Debt to NOPAT		 0.00 0.00 1.02 -5.96 2.57 0.00 0.00 -0.16 0.00 -0.06 0.00
Altman Z-Score		 8.20 0.00 11.12 12.33 11.21 14.74 -0.93 -6.14 -6.18 0.12 -1.92
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -10.22% -47.48% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.30 0.00 1.16 1.70 7.30 10.95 4.72 0.98 0.24 0.80 2.89
Quick Ratio		 0.25 0.00 0.96 1.51 7.03 9.28 4.43 0.80 0.22 0.73 2.70
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.05 -0.89 0.22 -0.74 -0.59 -3.25 -1.37 -0.71 -2.66 -93 -11
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 1,821.84% 172.37% -5,905.31% -11,356.99% 0.00% 0.00% -118,876.99% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.46 -5.89 1.29 -11.33 -2.53 -110.44 -57.97 -2.12 -2.33 -69.98 -2.74
Operating Cash Flow to Interest Expense		 0.76 -24.27 0.99 4.21 0.61 -75.36 -108.78 -4.65 -1.95 -10.68 -3.28
Operating Cash Flow Less CapEx to Interest Expense		 0.76 -24.27 0.99 3.98 0.26 -76.64 -109.74 -4.65 -1.95 -10.69 -3.28
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.79 0.00 9.49 2.69 1.91 2.23 1.27 2.16 0.17 0.00 0.00
Accounts Receivable Turnover		 8.28 0.00 0.00 10.18 12.13 12.76 6.89 12.74 1.47 0.05 0.18
Inventory Turnover		 0.00 0.00 0.00 0.00 37.53 17.37 7.83 77.68 39.55 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 78.28 101.50 75.74 125.03 37.51 10.93 26.16
Accounts Payable Turnover		 0.74 0.00 0.00 1.77 6.98 38.60 14.02 9.41 1.32 0.06 0.05
Days Sales Outstanding (DSO)		 44.10 0.00 0.00 35.87 30.08 28.62 52.99 28.65 248.18 7,178.27 2,063.95
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 9.73 21.02 46.62 4.70 9.23 0.00 0.00
Days Payable Outstanding (DPO)		 491.64 0.00 0.00 205.90 52.30 9.46 26.04 38.77 276.36 6,093.25 7,914.01
Cash Conversion Cycle (CCC)		 -447.54 0.00 0.00 -170.03 -12.49 40.18 73.58 -5.43 -18.95 1,085.02 -5,850.06
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -0.19 0.00 0.17 0.82 1.49 2.98 0.65 -0.68 -1.10 82 63
Invested Capital Turnover		 -25.92 0.00 34.38 7.74 6.43 7.65 5.45 -609.24 -1.53 0.00 0.01
Increase / (Decrease) in Invested Capital		 -0.15 0.19 0.17 0.65 0.67 1.49 -2.34 -1.33 -0.42 83 -19
Enterprise Value (EV)		 34 35 35 35 24 21 8.88 1.32 4.04 55 14
Market Capitalization		 34 35 35 35 27 27 12 2.34 4.04 52 21
Book Value per Share		 $0.01 $0.00 ($0.01) $0.03 $0.11 $1.07 $0.46 $0.08 $0.43 $9.22 $1.73
Tangible Book Value per Share		 $0.01 $0.00 ($0.01) $0.00 $0.09 $1.07 $0.46 $0.08 $0.43 ($2.18) ($0.02)
Total Capital		 0.50 0.00 0.35 1.69 4.37 8.90 3.77 0.84 0.54 82 70
Total Debt		 0.24 0.00 0.67 0.84 0.23 0.23 0.00 0.50 0.00 3.31 0.00
Total Long-Term Debt		 0.00 0.00 0.40 0.52 0.23 0.00 0.00 0.33 0.00 0.61 0.00
Net Debt		 0.16 0.00 0.48 -0.03 -2.65 -5.69 -3.12 -0.59 -0.00 3.00 -6.66
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.02 0.08 0.04 0.02 -0.00 0.00 0.01 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.08 0.00 0.16 0.06 0.41 2.68 0.33 -0.98 -8.80 0.79 -1.48
Debt-free Net Working Capital (DFNWC)		 -1.00 0.00 0.34 0.93 3.28 8.60 3.45 0.11 -8.80 1.10 5.18
Net Working Capital (NWC)		 -1.24 0.00 0.08 0.61 3.28 8.38 3.45 -0.05 -8.80 -1.60 5.18
Net Nonoperating Expense (NNE)		 1.02 2.06 0.11 -0.10 0.37 0.78 1.61 1.87 15 -19 12
Net Nonoperating Obligations (NNO)		 -0.45 0.00 0.48 -0.03 -2.65 -5.69 -3.12 -1.02 -1.64 3.00 -6.66
Total Depreciation and Amortization (D&A)		 0.11 0.11 0.09 0.00 0.09 0.10 0.14 0.19 1.05 0.97 3.65
Debt-free, Cash-free Net Working Capital to Revenue		 -37.09% 0.00% 5.48% 1.50% 5.52% 15.68% 3.29% -9.58% -645.51% 578.82% -343.12%
Debt-free Net Working Capital to Revenue		 -34.39% 0.00% 11.75% 24.20% 44.14% 50.25% 34.87% 1.10% -645.48% 804.29% 1,200.40%
Net Working Capital to Revenue		 -42.45% 0.00% 2.80% 15.81% 44.14% 48.94% 34.87% -0.52% -645.48% -1,171.97% 1,200.40%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($3.60) $0.00 $0.90 $0.00 ($0.75) ($4.95) ($9.75) $0.00 ($23.35) $2.69 ($2.70)
Adjusted Weighted Average Basic Shares Outstanding		 347.95K 355.12K 355.06K 358.45K 395.27K 539.55K 545.40K 564.86K 764.06K 3.38M 15.35M
Adjusted Diluted Earnings per Share		 ($3.60) $0.00 $0.90 $0.00 ($0.75) ($4.95) ($9.75) ($6.15) ($7.49) $2.48 ($2.70)
Adjusted Weighted Average Diluted Shares Outstanding		 347.95K 355.12K 378.74K 388.43K 395.27K 539.55K 545.40K 674.06K 2.38M 3.65M 15.35M
Adjusted Basic & Diluted Earnings per Share		 ($3.60) $0.00 $0.90 $0.00 $0.00 ($4.95) ($9.75) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 349.29K 350.50K 355.40K 374.74K 498.96K 513.71K 542.45K 674.06K 0.00 12.52M 40.63M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.10 -0.71 0.28 -0.06 0.09 -1.25 -3.22 -1.46 -2.02 -9.03 -9.92
Normalized NOPAT Margin		 -3.29% 0.00% 9.44% -1.60% 1.18% -7.28% -32.52% -14.25% -148.31% -6,605.37% -2,298.87%
Pre Tax Income Margin		 -8.81% 0.00% 7.56% 0.24% -4.79% -14.81% -53.75% -23.45% -621.99% -13,743.02% -10,080.22%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -1.15 -6.90 2.28 1.14 0.54 -85.29 -224.34 -6.21 -6.42 -13.16 -9.65
NOPAT to Interest Expense		 -0.80 -4.65 2.28 -1.35 0.38 -59.70 -157.04 -6.07 -2.69 -7.70 -7.30
EBIT Less CapEx to Interest Expense		 -1.15 -6.90 2.28 0.91 0.19 -86.57 -225.30 -6.21 -6.42 -13.17 -9.65
NOPAT Less CapEx to Interest Expense		 -0.80 -4.65 2.28 -1.58 0.02 -60.98 -158.00 -6.07 -2.69 -7.71 -7.30
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 163.90% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% -28.88% 0.00% 0.00% 0.00% 163.90% 0.00%

Quarterly Metrics And Ratios for Scienture

This table displays calculated financial ratios and metrics derived from Scienture's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 1,247,169.00 1,247,169.00 1,205,008.00 1,406,348.00 1,458,659.00 8,576,795.00 12,515,019.00 13,116,429.00 16,131,180.00 40,630,815.00 40,630,815.00
DEI Adjusted Shares Outstanding		 1,247,169.00 1,247,169.00 1,205,008.00 1,406,348.00 1,458,659.00 8,576,795.00 12,515,019.00 13,116,429.00 16,131,180.00 40,630,815.00 40,630,815.00
DEI Earnings Per Adjusted Shares Outstanding		 -2.83 -9.35 17.63 -1.30 -2.18 -0.84 -0.24 -0.51 -0.22 -0.69 -0.08
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -80.92% -93.33% -100.00% -94.90% -83.47% -52.48% 0.00% -100.00% 809.71% -417.80% 449.08%
EBITDA Growth		 236.62% -1,142.44% -542.18% 17.16% -854.70% -47.63% 71.25% -240.66% 98.56% -420.53% -59.97%
EBIT Growth		 174.80% -2,311.20% -511.79% 18.92% -1,930.59% -44.37% 63.34% -269.11% 39.74% -359.04% -44.65%
NOPAT Growth		 -248.18% -149.43% -581.43% -149.37% -359.22% -89.09% 34.98% -244.85% -24.68% -599.96% 1.73%
Net Income Growth		 -566.70% -795.27% 3,233.85% 7.14% 9.69% 38.60% -114.42% -266.46% -13.31% -292.59% -11.04%
EPS Growth		 -402.20% -831.10% 1,760.40% 55.17% 70.68% 86.12% -101.97% 63.08% 85.82% 19.81% 75.76%
Operating Cash Flow Growth		 -4.54% -185.55% -993.86% 1,184.96% -793.38% -185.48% 70.99% -148.18% 40.36% -77.88% 1.26%
Free Cash Flow Firm Growth		 -2,355.52% -262.55% -904.80% -256.98% -345.14% -7,433.09% -546.43% -1,706.02% 95.26% 97.64% 121.89%
Invested Capital Growth		 993.30% -61.21% 1,513.91% 176.64% 403.98% 7,573.35% 985.52% 5,141.01% 0.32% -22.68% -23.50%
Revenue Q/Q Growth		 7.03% -71.53% -100.00% 0.00% 246.87% -18.16% -80.68% -100.00% 0.00% -128.59% 133.39%
EBITDA Q/Q Growth		 119.66% -1,034.59% -79.78% 74.92% -79.11% -82.82% 64.99% -197.13% 99.24% -65,787.52% 89.24%
EBIT Q/Q Growth		 107.99% -2,777.02% -50.61% 74.83% -80.37% -111.12% 61.76% -153.46% 70.55% -1,508.32% 87.95%
NOPAT Q/Q Growth		 -26.99% -192.63% -146.44% 72.77% -133.86% -20.49% 15.26% -44.43% 15.45% -576.43% 88.10%
Net Income Q/Q Growth		 -78.50% -230.93% 282.13% -108.63% -73.60% -124.99% 57.22% -119.34% 46.32% -679.53% 87.90%
EPS Q/Q Growth		 -57.59% -234.14% 209.82% -107.75% -3.08% -58.21% 84.43% -45.45% 60.42% -794.74% 95.29%
Operating Cash Flow Q/Q Growth		 -283.56% -68.98% -899.86% 141.43% -227.62% 46.00% -1.62% 31.19% -57.98% -61.04% 43.59%
Free Cash Flow Firm Q/Q Growth		 -632.61% 92.75% -950.00% 61.26% -1,410.32% -22.61% 9.90% -8.24% 96.04% 38.84% 934.67%
Invested Capital Q/Q Growth		 922.55% -106.54% 793.86% -79.48% 5,309.07% -2.95% 0.78% -0.94% 3.54% -25.21% -0.28%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 10.09% -117.20% 0.00% -3.76% 5.99% 5.32% 6.56% 0.00% 97.39% 0.00% 95.61%
EBITDA Margin		 99.97% -3,281.31% 0.00% -8,837.16% -4,563.29% -10,193.46% -18,468.64% 0.00% -7.24% 0.00% -5,380.52%
Operating Margin		 -194.16% -1,995.40% 0.00% -7,998.78% -5,392.75% -7,939.57% -34,814.94% 0.00% -739.12% 0.00% -6,230.80%
EBIT Margin		 41.72% -3,921.81% 0.00% -8,881.88% -4,618.51% -11,914.02% -23,578.23% 0.00% -305.91% 0.00% -6,211.43%
Profit (Net Income) Margin		 -898.61% -10,443.53% 0.00% -9,807.49% -4,908.34% -13,493.46% -29,869.34% 0.00% -611.37% 0.00% -6,040.42%
Tax Burden Percent		 3,999.63% 231.96% -320.29% 112.87% 100.00% 97.62% 100.00% 100.00% 100.00% 93.38% 100.00%
Interest Burden Percent		 -53.86% 114.80% 100.54% 97.83% 106.28% 116.01% 126.68% 109.63% 199.85% 103.73% 97.25%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -43.45% 0.00% 0.00% 0.00% -14.55% -18.76% -79.26% 0.00% -3.99% 0.00% -28.54%
ROIC Less NNEP Spread (ROIC-NNEP)		 -154.28% 0.00% 0.00% 0.00% -46.10% -637.69% -53.87% 0.00% -72.69% 0.00% 66.60%
Return on Net Nonoperating Assets (RNNOA)		 -64.49% 0.00% 0.00% 0.00% -2.22% -10.90% 2.53% 0.00% -0.70% 0.00% -0.89%
Return on Equity (ROE)		 -107.94% -4,031.44% 0.00% 80.48% -16.77% -29.66% -76.73% 0.00% -4.69% 0.00% -29.44%
Cash Return on Invested Capital (CROIC)		 -187.83% 0.00% -190.51% -677.26% -151.34% -113.88% -186.06% -220.08% -14.62% -15.39% -14.15%
Operating Return on Assets (OROA)		 9.27% -658.59% 0.00% -499.36% -15.56% -27.74% -56.28% 0.00% -2.01% 0.00% -31.73%
Return on Assets (ROA)		 -199.72% -1,753.77% 0.00% -551.40% -16.54% -31.41% -71.29% 0.00% -4.01% 0.00% -30.86%
Return on Common Equity (ROCE)		 -108.29% -5,945.42% 0.00% 80.48% -16.77% -29.66% -76.73% 0.00% -4.69% 0.00% -29.44%
Return on Equity Simple (ROE_SIMPLE)		 -64.72% 0.00% 29.96% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.53 -1.56 -3.85 -1.05 -2.45 -2.95 -2.50 -3.61 -3.05 -21 -2.46
NOPAT Margin		 -135.91% -1,396.78% 0.00% -5,599.14% -3,774.92% -5,557.70% -24,370.46% 0.00% -517.39% 0.00% -4,361.56%
Net Nonoperating Expense Percent (NNEP)		 110.83% -758.47% 697.66% -14.35% 31.55% 618.93% -25.39% -101.32% 68.70% -408.18% -95.15%
Return On Investment Capital (ROIC_SIMPLE)		 - -287.68% -28.23% -8.88% -2.79% -3.58% -2.95% -4.41% -3.58% -29.45% -3.68%
Cost of Revenue to Revenue		 89.91% 217.20% 0.00% 103.76% 94.01% 94.68% 93.44% 0.00% 2.61% 0.00% 4.39%
SG&A Expenses to Revenue		 92.38% 991.19% 0.00% 4,944.42% 1,174.84% 2,956.93% 17,243.11% 0.00% 590.84% 0.00% 3,563.99%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 1,933.34% 1,851.27% 5,602.25% 0.00% 28.70% 0.00% 1,409.65%
Operating Expenses to Revenue		 204.26% 1,878.19% 0.00% 7,995.02% 5,398.74% 7,944.89% 34,821.51% 0.00% 836.51% 0.00% 6,298.42%
Earnings before Interest and Taxes (EBIT)		 0.16 -4.38 -6.60 -1.66 -3.00 -6.32 -2.42 -6.13 -1.81 -29 -3.50
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 0.39 -3.67 -6.59 -1.65 -2.96 -5.41 -1.89 -5.63 -0.04 -28 -3.03
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.47 7.44 0.85 1.24 0.13 0.66 0.22 0.18 0.17 0.30 0.17
Price to Tangible Book Value (P/TBV)		 0.00 7.44 0.85 1.24 12.52 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 1.87 2.96 13.23 28.04 56.62 379.75 122.68 106.40 20.97 48.01 24.24
Price to Earnings (P/E)		 0.00 0.00 2.82 3.47 2.42 5.72 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 83.73% 76.76% 125.33% 157.02% 659.72% 913.46% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 35.44% 28.80% 41.27% 17.47% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.64 0.00 0.72 2.84 0.12 0.67 0.24 0.22 0.19 0.22 0.13
Enterprise Value to Revenue (EV/Rev)		 3.65 2.96 6.34 8.49 53.77 401.73 133.28 138.21 24.30 32.58 16.83
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.45 0.00 0.00 0.00 0.03 0.04 0.04 0.05 0.03 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.03 0.01 0.01 0.02 0.00 0.00 0.00
Financial Leverage		 0.42 -3.01 -0.50 -1.05 0.05 0.02 -0.05 -0.07 0.01 -0.02 -0.01
Leverage Ratio		 2.04 18.35 1.46 1.77 1.20 1.47 1.30 1.33 1.19 1.27 1.26
Compound Leverage Factor		 -1.10 21.06 1.46 1.73 1.27 1.71 1.65 1.46 2.37 1.31 1.23
Debt to Total Capital		 31.25% 0.00% 0.00% 0.00% 2.88% 4.02% 4.26% 4.99% 2.97% 0.00% 0.00%
Short-Term Debt to Total Capital		 31.10% 0.00% 0.00% 0.00% 0.30% 3.28% 2.97% 3.07% 2.97% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.15% 0.00% 0.00% 0.00% 2.57% 0.74% 1.29% 1.93% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 68.75% 100.00% 100.00% 100.00% 97.12% 95.98% 95.74% 95.01% 97.03% 100.00% 100.00%
Debt to EBITDA		 -2.31 0.00 0.00 0.00 -0.17 -0.20 -0.30 -0.26 -0.20 0.00 0.00
Net Debt to EBITDA		 -2.29 0.00 0.00 0.00 0.04 -0.18 -0.13 -0.26 -0.17 0.00 0.00
Long-Term Debt to EBITDA		 -0.01 0.00 0.00 0.00 -0.15 -0.04 -0.09 -0.10 0.00 0.00 0.00
Debt to NOPAT		 -2.69 0.00 0.00 0.00 -0.28 -0.32 -0.40 -0.36 -0.21 0.00 0.00
Net Debt to NOPAT		 -2.67 0.00 0.00 0.00 0.06 -0.29 -0.17 -0.35 -0.18 0.00 0.00
Long-Term Debt to NOPAT		 -0.01 0.00 0.00 0.00 -0.25 -0.06 -0.12 -0.14 0.00 0.00 0.00
Altman Z-Score		 -1.10 -5.40 -0.30 0.79 0.17 0.47 -0.19 -0.62 -0.45 -1.51 -1.06
Noncontrolling Interest Sharing Ratio		 -0.33% -47.48% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.61 0.24 4.75 4.18 1.34 0.80 1.05 0.11 0.19 2.89 1.70
Quick Ratio		 0.25 0.22 4.69 3.88 1.18 0.73 0.99 0.00 0.13 2.70 1.52
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -16 -1.14 -12 -4.65 -70 -86 -78 -84 -3.33 -2.03 17
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -62.67 -1.76 -121.85 -939.70 -323.04 -84.87 -115.68 -128.53 -1.84 -2.13 458.78
Operating Cash Flow to Interest Expense		 -2.40 -1.57 -103.43 853.09 -24.78 -2.87 -4.41 -3.11 -1.78 -5.42 -78.86
Operating Cash Flow Less CapEx to Interest Expense		 -1.84 -1.57 -103.43 853.09 -24.78 -2.87 -4.41 -3.11 -1.78 -5.42 -78.86
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.22 0.17 0.08 0.06 0.00 0.00 0.00 0.00 0.01 0.00 0.01
Accounts Receivable Turnover		 2.18 1.47 0.18 0.34 0.07 0.05 0.02 0.00 0.26 0.18 0.20
Inventory Turnover		 0.71 39.55 13.59 7.33 0.21 0.00 0.00 0.00 0.62 0.00 0.00
Fixed Asset Turnover		 16.45 37.51 25.09 15.82 1.28 10.93 12.24 11.15 39.01 26.16 29.85
Accounts Payable Turnover		 1.07 1.32 1.22 0.77 0.15 0.06 0.07 0.06 0.02 0.05 0.04
Days Sales Outstanding (DSO)		 167.78 248.18 2,045.38 1,062.60 5,123.72 7,178.27 16,269.48 0.00 1,426.24 2,063.95 1,822.44
Days Inventory Outstanding (DIO)		 511.39 9.23 26.85 49.79 1,714.70 0.00 0.00 0.00 587.72 0.00 0.00
Days Payable Outstanding (DPO)		 341.66 276.36 299.62 472.00 2,391.51 6,093.25 5,385.43 5,834.61 15,946.06 7,914.01 9,004.76
Cash Conversion Cycle (CCC)		 337.51 -18.95 1,772.61 640.39 4,446.90 1,085.02 10,884.05 -5,834.61 -13,932.09 -5,850.06 -7,182.32
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 17 -1.10 7.62 1.56 85 82 83 82 85 63 63
Invested Capital Turnover		 0.32 -1.53 0.25 -2.19 0.00 0.00 0.00 0.00 0.01 0.01 0.01
Increase / (Decrease) in Invested Capital		 15 -0.42 8.16 3.60 68 83 75 80 0.27 -19 -19
Enterprise Value (EV)		 11 4.04 5.51 4.44 10 55 20 18 16 14 8.04
Market Capitalization		 5.46 4.04 12 15 11 52 18 14 14 21 12
Book Value per Share		 $9.27 $0.43 $11.30 $8.38 $58.36 $9.22 $6.49 $5.94 $5.12 $1.73 $1.64
Tangible Book Value per Share		 ($2.42) $0.43 $11.30 $8.38 $0.61 ($2.18) ($1.33) ($1.52) ($0.94) ($0.02) ($0.09)
Total Capital		 17 0.54 14 12 88 82 85 82 85 70 67
Total Debt		 5.26 0.00 0.00 0.00 2.52 3.31 3.61 4.09 2.53 0.00 0.00
Total Long-Term Debt		 0.03 0.00 0.00 0.00 2.26 0.61 1.09 1.58 0.00 0.00 0.00
Net Debt		 5.22 -0.00 -6.00 -10 -0.56 3.00 1.56 4.08 2.18 -6.66 -3.54
Capital Expenditures (CapEx)		 -0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 1.65 -8.80 7.58 1.52 1.53 0.79 0.83 -4.33 -3.76 -1.48 -1.57
Debt-free Net Working Capital (DFNWC)		 1.69 -8.80 11 9.24 2.11 1.10 2.88 -4.32 -3.40 5.18 1.97
Net Working Capital (NWC)		 -3.54 -8.80 11 9.24 1.84 -1.60 0.36 -6.83 -5.93 5.18 1.97
Net Nonoperating Expense (NNE)		 2.99 10 -25 0.79 0.74 4.21 0.56 3.11 0.55 7.47 0.95
Net Nonoperating Obligations (NNO)		 5.22 -1.64 -6.00 -10 -0.56 3.00 1.56 4.08 2.18 -6.66 -3.54
Total Depreciation and Amortization (D&A)		 0.23 0.72 0.01 0.01 0.04 0.91 0.52 0.50 1.76 0.87 0.47
Debt-free, Cash-free Net Working Capital to Revenue		 56.41% -645.51% 870.36% 291.26% 782.73% 578.82% 564.27% -3,379.02% -574.70% -343.12% -329.17%
Debt-free Net Working Capital to Revenue		 57.58% -645.48% 1,272.29% 1,768.24% 1,079.31% 804.29% 1,959.52% -3,367.01% -520.27% 1,200.40% 412.49%
Net Working Capital to Revenue		 -121.08% -645.48% 1,272.29% 1,768.24% 943.59% -1,171.97% 247.49% -5,328.76% -907.63% 1,200.40% 412.49%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($4.57) ($15.27) $20.49 ($1.30) ($1.34) ($2.12) ($0.33) ($0.48) ($0.19) ($1.70) ($0.08)
Adjusted Weighted Average Basic Shares Outstanding		 771.19K 764.06K 1.04M 1.41M 2.37M 3.38M 9.43M 14.14M 18.96M 15.35M 40.63M
Adjusted Diluted Earnings per Share		 ($1.49) ($15.27) $16.77 ($1.30) ($1.34) ($2.12) ($0.33) ($0.48) ($0.19) ($1.70) ($0.08)
Adjusted Weighted Average Diluted Shares Outstanding		 2.36M 2.38M 1.27M 1.41M 2.37M 3.65M 9.43M 14.14M 18.96M 15.35M 40.63M
Adjusted Basic & Diluted Earnings per Share		 $0.00 ($15.27) $0.00 $0.00 $0.00 ($2.12) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 1.41M 1.46M 8.58M 12.52M 13.12M 16.13M 40.63M 40.63M 40.63M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.25 -1.05 -3.61 -0.93 -2.01 -2.48 -2.17 -3.34 -2.34 -21 -2.23
Normalized NOPAT Margin		 -62.85% -942.83% 0.00% -4,956.35% -3,106.64% -4,664.87% -21,157.58% 0.00% -396.53% 0.00% -3,956.19%
Pre Tax Income Margin		 -22.47% -4,502.21% 0.00% -8,688.92% -4,908.34% -13,821.96% -29,869.34% 0.00% -611.37% 0.00% -6,040.42%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.65 -6.76 -66.97 -335.59 -13.78 -6.23 -3.61 -9.38 -1.00 -30.38 -94.51
NOPAT to Interest Expense		 -2.12 -2.41 -39.03 -211.55 -11.26 -2.91 -3.73 -5.53 -1.69 -21.61 -66.36
EBIT Less CapEx to Interest Expense		 1.20 -6.76 -66.97 -335.59 -13.78 -6.23 -3.61 -9.38 -1.00 -30.38 -94.51
NOPAT Less CapEx to Interest Expense		 -1.57 -2.41 -39.03 -211.55 -11.26 -2.91 -3.73 -5.53 -1.69 -21.61 -66.36
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 310.53% 300.16% 325.64% 163.90% 0.00% -10.87% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 310.53% 300.16% 325.64% 163.90% 0.00% -10.87% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Scienture Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Scienture's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Scienture's net income appears to be on an upward trend, with a most recent value of -$41.51 million in 2025, rising from -$1.12 million in 2015. The previous period was $9.07 million in 2024. See Scienture's forecast for analyst expectations on what's next for the company.

Scienture's total operating income in 2025 was -$42.59 million, based on the following breakdown:
  • Total Gross Profit: $331.48 thousand
  • Total Operating Expenses: $42.83 million

Over the last 10 years, Scienture's total revenue changed from $2.91 million in 2015 to $431.61 thousand in 2025, a change of -85.2%.

Scienture's total liabilities were at $14.06 million at the end of 2025, a 45.5% decrease from 2024, and a 698.5% increase since 2015.

In the past 10 years, Scienture's cash and equivalents has ranged from $0.00 in 2016 to $6.66 million in 2025, and is currently $6.66 million as of their latest financial filing in 2025.

Over the last 10 years, Scienture's book value per share changed from 0.01 in 2015 to 1.73 in 2025, a change of 20,203.5%.


Related Companies

Financial statements for NASDAQ:SCNX last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel